|
 |
 |
Condensed Interim Financial Information for the Quarter
Ended September 30, 2011 |
|
|
Financial Statements For The Year Ended June 30, 2011 |
|
|
Condensed Interim Financial Information for the
Quarter/Nine Months Ended March 31, 2011 |
|
|
Condensed Interim Financial Information for the Quarter/Six Months Ended December 31, 2010 |
|
|
Condensed Interim Financial Information for the Quarter
ended September, 2010 |
|
|
Individual Financial Statements For The Year Ended June 30, 2010 |
|
|
Consolidated Financial Statements For The Year Ended June 30, 2010 |
|
|
Condensed Interim Financial Information for the Quarter/Nine Months Ended March 31, 2010 |
|
|
Condensed Interim Financial Information for the Quarter/Six Months Ended December 31, 2009 |
|
|
Condensed Interim Financial Information for the Quarter Ended September 30, 2009 |
|
|
Financial Statements For The Year Ended June 30, 2009 |
|
|
Previous Financial Statements |
|
|
Media
Kit |
|
|
Stock
Price |
|
 |
|
 |
 |
 |
 |
|
|
View a listing
of links to medical journals on the Web.Go
to Links.
|
|
| |
|
|
|
 |
|
|
 |
 |
 |
 |
|
|
| |
 |
 |
August 2004: Levo (Levofloxacin 250 mg, 500 mg tablets) launched |
|
|
April 2004: Ferozsons launches Caliptrol (atorvastatin 10, 20, 40 mg) tablets |
|
|
October 2003: Ferozsons launches Carveda (carvedilol 6.25, 25 mg) tablets |
|
|
July 2003 : Ferozsons announces Omega (omeprazole) infusion |
|
|
June 2003: Ferozsons launches Oncology Divsion with Filgen and Panataxel |
|
|
2003: Ferozsons gets ISO 9001:2000 Certification |
|
 |
All Rights Reserved. Copyrights
© 2004 Ferozsons Laboratories Limited, Rawalpindi, Pakistan
Privacy Policy | Web Design and development: Dr. Mustafa Ahmed Sarfaraz |
|
